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Physician–patient relationsPurpose. Primary care providers (PCPs) play an important role in identifying and counseling obese patients
to lose weight, but it is unknown whether PCP referral of patients into a weight loss intervention is associated
with greater weight loss. The objectives are to determine if PCP referral is associated with greater 1) weight
loss, 2) end of study patient–provider relationship quality, and 3) satisfaction and participation rates in the
intervention.
Methods. 415 obese patients enrolled in the Hopkins POWER trial from six primary care practices in the Bal-
timore area. We conducted a secondary analysis of results from the trial using longitudinal mixed-effects model
and generalized linear model, adjusting for clinic, sex, age, and race. The primary outcome was absolute weight
change from baseline to 24 months. Secondary outcomes were patient–provider relationship quality and satis-
faction and participation rates in the intervention.
Results. Participants in both PCP and non-PCP referral groups lost a similar amount of weight from baseline
to 24 months. PCP referral was not signiﬁcantly associated with percentage of completed coach contacts, web
logins, and satisfaction with trial, but was associated with higher end of study patient–provider relationship
quality (p = 0.007).
Conclusions. Our study represents the ﬁrst of its kind to examine the role of PCP referral of patients into a
weight loss trial.Whilewe did notﬁnd evidence that PCP referral is associatedwith increasedweight loss, further
research is needed to determine how PCPs can use their relationship with patients to promote weight loss and
enhance intervention effects.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Primary care providers (PCPs) play an important role in identifying
and counseling obese patients to lose weight. The U.S. Preventive Ser-
vices Task Force recommends that clinicians screen all adult patients
for obesity and “offer intensive counseling and behavioral interventions
to promote sustained weight loss for obese adults” (Preventive Services
Task Force, 2003). However, physicians report barriers to conducting
weight loss counseling, including lack of time and training, and many
prefer referring patients into effective weight loss programs (Kushner,
1995; Forman-Hoffman et al., 2006; Bennett et al., 2014). A recent sys-
tematic review evaluating primary care based behavioral treatment of
obesity found that provider-led interventions were less effective than
those using trained coaches or interventionists (Wadden et al., 2014).
The review highlighted the need to better understand and re-deﬁnernal Medicine, Department of
024 E. Monument St., Room 2-
5 0476.
. This is an open access article underPCP involvement in weight loss programs to fully take advantage of
the PCPs' potential impact on patients' long-term weight loss.
The Johns Hopkins Practice-based Opportunities for Weight Reduc-
tion (POWER) Trial was identiﬁed in the systematic review for evaluat-
ing intensive behavioral counseling led by interventionists (Appel et al.,
2011). The POWER trial was a randomized controlled trial evaluating
the effectiveness of two behavioral weight loss interventions, remote
or in-person coaching focused on nutrition and exercise, in addition to
a control arm. One of the main roles of the PCPs was recommending
and referring eligible patients into the study (Bennett et al., 2014).
Recruiting patients and participants into a randomized controlled
trial can be extremely difﬁcult, and evidence on the effectiveness of re-
cruitment strategies has been limited. A Cochrane review of controlled
trials on recruitmentmethod, identiﬁed several strategies for increasing
recruitment of participants to randomized controlled trials, including
telephone reminders to non-responders, open-trial designs, opt-out
procedures for contacting potential participants, and ﬁnancial incen-
tives (Treweek et al., 2010). To our knowledge, no prior studies have
examined the role of PCP referral on the recruitment of participants
into a weight loss trial.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the association between being referred into the trial by a PCP and
subsequent weight loss, patient–provider relationship quality, and par-
ticipation. Our study objectives are to determine if PCP referral is associ-
ated with greater 1) weight loss, 2) end of study patient–provider
relationship quality, and 3) satisfaction and participation rates in the
intervention. We also explored whether the associations differed
among the three arms of the study. We hypothesized that participants
referred by their PCP would achieve greater weight loss because PCP
referral potentially represented patient–provider communication
regarding the diagnosis and treatment of obesity and endorsement
of the study as a way to lose weight. Additionally, we hypothesized
that PCP referral would be associated with greater patient–provider
relationship quality and higher participation and satisfaction rates in
the intervention.Methods
The POWER trial design
Details of the study design and main results of the trial have been
published previously (Appel et al., 2011). Brieﬂy, the Hopkins POWER
trial was a 3-arm randomized controlled trial of 415 obese patients,
ages 21 and older with BMI ≥ 30 kg/m2, and at least one cardiovascular
risk factor (hypertension, hypercholesterolemia or diabetes). The main
exclusion criteria included recent weight loss of 5% or more of body
weight, prior or planned bariatric surgery, and use of prescription
weight loss medication within 6 months. Details regarding additional
inclusion and exclusion criteria for the trial are outlined in the main
trial paper (Appel et al., 2011). Based on a power calculation for the
original trial to detect a between-group difference in weight change of
2.75 kg for at least one of the two comparisons (remote support vs. con-
trol and in-person support vs. control), 415 participants were random-
ized 1:1:1 to the three arms over 24 months. Participants attended in-
person visits at baseline, 6, 12 and 24 months after randomization.
Common features of both intervention groups (remote and in-
person support) included weight-loss coaches and online educational
modules, including self-monitoring tools and graphs. In the remote sup-
port intervention, contact with the health coach was via telephone
whereas in the in-person support intervention it was via face-to-face
group and individual sessions either in-person or by telephone. The
control arm met with a weight loss coach at the time of randomization
along with receiving brochures and a list of weight loss websites. PCPs
referred patients to the trial, encouraged their participation in the inter-
vention, and reviewed weight loss progress reports at routine ofﬁce
visits with patients assigned to an intervention group. The Institutional
Review Board of The Johns Hopkins University School of Medicine
approved the POWER trial.Independent variable — PCP referral as mode of recruitment
Participants were recruited from six primary care practices in the
Baltimore metropolitan area between February 2008 and February
2009 by several methods. First, each clinic mailed letters to patients
who were potentially eligible (i.e., BMI ≥ 30 kg/m2 and at least one car-
diovascular risk factor). Second, PCPs could directly refer patients who
potentially ﬁt the inclusion criteria. Third, participants could learn of
the trial from brochures, posters and website announcements at the
participating clinics. We deﬁned the mode of recruitment according to
participants' response to the telephone screening question, “How did
you hear about POWER?” Study recruiters recorded up to three re-
sponses per participant. For the analysis, responses were dichotomized
into “PCP referral” if “physician”was included as one of the three possi-
ble responses, versus “non-PCP referral” for all others.Primary Outcome: weight change over 2-year trial
Our primary outcome for this secondary data analysis was absolute
weight change from baseline to 24 months. Weight was measured in
pounds using a calibrated, high-quality digital scale (Tanita BWB 800
digital scale) with the participant wearing light, indoor clothes without
shoes. Measurements were taken by trained research staff who were
blinded to the treatment assignment of the participant.
Secondary outcomes: patient–provider relationship quality, participation
and satisfaction in the intervention
We assessed the secondary outcome of end of study patient–provid-
er relationship quality using a questionnaire adapted from the validated
Consumer Assessment of Healthcare Providers and Systems (CAHPS)
Adult 12 month survey, 2.0 (Treweek et al., 2010). The questions were
scored using a Likert response scale (1 = never to 4 = always) and
asked how often their PCP seemed to know their medical history,
explain things clearly, and understand their values and beliefs
(Consumer Assessment of Healthcare Providers and Systems (CAHPS)
surveys). For our analysis, the total score from the questionnaire was
used as a continuous outcome.
Among the 277 participants randomized to the active intervention
arms, we assessed the participation rate and satisfaction with the inter-
vention and PCP's involvement. The participation rate was assessed as
the percentage of completed recommended coach contacts and web
logins. Satisfaction with their PCP's and coach's involvement was mea-
sured with an end of study questionnaire assessing how helpful were
the telephone calls, in-person visits, website and online modules. The
questions were scored on a 5-point Likert scale (0 = did not use or
not at all helpful to 4 = extremely helpful). For the analysis, we added
up the total score andweighted it by thenumber of answered questions.
Additionally, we looked separately at two of the survey questions
assessing participant's satisfaction with their PCP: “How helpful was
your primary care provider's involvement in the POWER study?” and
“How helpful was reviewing your self-monitoring weight graph with
your PCP?” The total score, weighted by the number of questions
answered, was used as the outcome in themodel. Finally, we calculated
the total number of reports reviewed by the PCPwith their patient over
24 months.
Covariates
For the main analysis, we separated the two interventions arms,
which we contrasted with the control arm. In the stratiﬁed analysis,
we combined the two intervention arms. Other covariates in the
model included participants' age, gender, race and primary care clinic
site.
Statistical analysis
We assessed the association between PCP referral and weight
change from baseline to 24 months using a longitudinal mixed-effects
model. For the main analysis, we used a repeated measures model for
visit-speciﬁc weight, including visit indicators (6, 12, and 24 months),
randomization assignment and their cross-product interaction terms,
adjusting for clinic, sex, age, and race. We also included the PCP referral
status indicator and its cross-product interaction termswith the visit in-
dicators. For themain objective, we examined the regression coefﬁcient
for the interaction of PCP referral and the 24-month visit indicator. Ef-
fect modiﬁcation by recruitment method on the effectiveness of the in-
terventions at 24 months was also explored with the 3-way interaction
term of PCP referral status by randomization arm by visit.
We examined effectmodiﬁcation by gender and diabetes status sep-
arately on the primary outcome of weight loss. The rationale was to de-
termine if PCP referral had a greater effect on males because our earlier
970 E. Tseng et al. / Preventive Medicine Reports 2 (2015) 968–972qualitative research suggested that men may be more likely to partici-
pate in the trial because it is perceived as “medically supervised”
(Bennett et al., 2014). Participants with diabetes may be more likely
to be referred by providers for weight loss, andwewanted to assess dif-
ferential beneﬁt.
Additionally, we performed a sensitivity analysis to assessmisclassi-
ﬁcation of participants into PCP referral groups. In this analysis, we
reclassiﬁed those who had reported “physician” aswell as other referral
methods as “non-PCP referral” and only those with “physician” listed
were classiﬁed as “PCP referral.”
For the secondary outcome of end of study patient-provider rela-
tionship quality, we conducted general linear regression adjusting for
clinic, sex, age, randomization assignment and race. For the outcomes
of satisfaction and participation rates, we used general linear regression,
adjusting for clinic, sex, age, and race.
All analyses were conducted using SAS software, version 9.4
(SAS Institute).
Results
Of the 415 POWER trial participants, 171 (41%) reported PCP referral
compared to 244 (59%) who reported non-PCP referral methods, which
included, not exclusively, letters (81%), brochures (12%), friends (3%)
and posters (2%). Those referred by their PCP were slightly younger
(52.8 vs. 54.9 years, p = 0.04) and more likely to be female (71.4% vs.
58.2%, p b 0.001). Participants in both groups were equally distributed
among the three treatment arms. Therewas no difference in the propor-
tion of participants with diabetes and three co-morbid conditions
(Table 1). Participants referred by their PCP tended to have a higherTable 1
Baseline characteristics of studyparticipants inPCP vs. non-PCP referral groups in theHop-
kins POWER trial conducted in the Baltimore area.
Characteristic PCP referral
(n = 171)
Non-PCP referral
(n = 244)
p-Value
Age — yr ± SD 52.8 ± 10.2 54.9 ± 10.2 0.04
Weight — kg ± SD 105.8 ± 18.9 102.4 ± 17.2 0.06
BMI (kg/m2) 37.6 ± 5.3 35.9 ± 4.7 b0.001
Treatment arm, n (%)
In-person directed 55 (32.2) 83 (34.0) 0.91
Remote directed 59 (34.5) 80 (32.8)
Control 57 (33.3) 81 (33.2)
Race, n (%)
Asian 2 (1.2) 2 (0.8) 0.28
Black 79 (46.2) 91 (37.3)
White 87 (50.9) 146 (59.8)
Other 3 (1.8) 5 (2.1)
Hispanic 2 (1.2) 7 (2.9) 0.32
Education, n (%)
High school graduate or less 21 (12.3) 23 (9.4) 0.61
Some college 49 (28.7) 76 (31.2)
College graduate 101 (59.1) 145 (59.4)
Female sex, n (%) 122 (71.4) 142 (58.2) 0.006
Household income, n (%)
b$50,000 37 (21.6) 54 (22.1)
$50,000–99,999 64 (37.4) 91 (37.3)
≥$100,000 70 (40.9) 99 (40.6) 0.99
Employment status, n (%)
Employed 130 (76.0) 182 (74.6) 0.26
Retired 22 (12.9) 43 (17.6)
Other 19 (11.1) 19 (7.8)
Health insurance, n (%)
Private or HMO 169 (98.8) 235 (96.3) 0.13
Medicare 12 (7.0) 32 (13.1) 0.05
Medicaid 0 2 (0.8) 0.24
Uninsured 1 (0.6) 3 (1.2) 0.65
Medical conditions, n (%)
Hypertension 131 (76.6) 185 (76.1) 0.91
Diabetes 45 (26.3) 51 (20.9) 0.20
Hypercholesterolemia 106 (62.0) 175 (71.7) 0.04
1 comorbid condition 69 (43.1) 91 (56.9) 0.53
3 comorbid conditions 32 (52.5) 29 (47.5) 0.28baseline mean (±SD) weight (105.8 ± 18.9 kg vs. 102.4 ± 17.2 kg;
p = 0.06). This baseline weight difference between groups was highly
signiﬁcant for the in-person support arm (8.7 kg, p = 0.01) after
adjusting for clinic, sex, age, and race.
Participants in both referral groups lost weight from baseline to
24 months in equal amounts after adjusting for age, race, gender
and clinic site (Fig. 1). Examining the 3 arms separately, we found a
statistically non-signiﬁcant trend towards greater weight loss among
participants referred by their PCP within the in-person support arm
(between-group difference at 24 months: −2.7 kg, 95%CI −5.8 to
0.4 kg) (Fig. 1) and found no difference in the remote support arm
(between-group difference: −0.3 kg, 95%CI −3.3 to 2.7 kg) or the
control arm (between-group difference: 0.0 kg, 95%CI−2.6 to 2.6 kg)
at 24 months. However, the overall difference among the 3 treatment
arms was statistically signiﬁcant (likelihood ratio test with 2
degrees of freedom = 8.4, p = 0.015), with a difference of −2.7 kg
(95%CI −6.8 to 1.3 kg, p = 0.19) between in-person support and
control arms, and−2.4 kg (95%CI−6.7 to 1.9 kg, p = 0.27) between
in-person and remote support arms. We did not detect effect modiﬁca-
tion by recruitment method on the effectiveness of the interventions
(p = 0.55).
We examined if PCP referral had a differential effect on weight loss
by gender and by diabetes status (Table 2). In the combined interven-
tion arms, men who were referred by their PCP tended to lose more
weight by 24 months (between-group difference: −3.1 kg, 95%CI
−8.0 to 1.7 kg). However, gender did not modify the interaction of re-
cruitment method and the intervention effect at 24 months. Partici-
pants, with and without diabetes, had a similar degree of weight loss
at 24 months, and we did not identify any interaction (Table 2). In our
sensitivity analysis, 81 out of 171 participants were re-classiﬁed from
the original PCP referral group into the non-PCP referral group, as they
had listed multiple recruitment methods (n= 90 (22%) for PCP referral
and n = 325 (78%) for non-PCP referral). Our results for the primary
outcome of absolute weight loss were unchanged in the sensitivity
analysis.
Participants' referred by their PCP to the trial rated the quality of
their relationship with their PCP higher (p = 0.007). However, among
participants in the intervention arms (n = 277), PCP referral was not
signiﬁcantly associated with greater participation in the intervention,
including percentage of completed coach contacts and web logins
(Table 3). In terms of satisfaction with the intervention's components,
both referral groups had similar total satisfaction scores (p = 0.31).
We did not identify differences on the two questions addressing satis-
faction with the PCP's involvement in the study (p = 0.13). Finally,
the mean number of weight loss reports reviewed by PCPs was similar
during the 2-year trial (2.3 vs. 2.1 reports, in the PCP and non-PCP
referral groups, respectively [Table 3]).
Discussion
To better understand the role of PCPs in a primary care practice-
based weight loss trial, we described the characteristics of patients re-
ferred by their PCP into the Hopkins POWER trial and assessed whether
the type of enrollment (PCP referral vs. other) was associated with
weight loss, patient–provider relationship quality, and satisfaction and
participation rates in the trial. We found that PCPs referred patients
who were heavier and female. Although the overall representation of
males in the trial was higher than most studies, males were referred
less often by PCPs than females. Prior research has shown that men
are underrepresented in weight loss interventions (Pagoto et al., 2012;
Young et al., 2012) and less likely to receive weight loss counseling
(Ko et al., 2008).
We found no evidence that PCP referral was associated with
signiﬁcantly greater weight loss at 24 months over and above what is
imparted by the study interventions, nor with greater adherence to
the intervention program components. However, we found a consistent
Fig. 1.Mean weight change between PCP-referral and non-PCP referral groups, by randomized group (control, in-person support, remote support). See attachment for Fig. 1.
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within the in-person support armat 24months (Fig. 1). PCP-referred in-
dividuals in this arm were about 10% heavier at baseline than their
counterparts, suggesting that PCPs may have been more involved and
engaged with these heavier patients during the trial leading to greater
weight loss. Moreover, while statistically non-signiﬁcant, there was a
between-group difference in weight loss of 3.1 kg between males in
the intervention arms who were and were not referred by their PCP
(Table 2). This ﬁnding is clinically important since men are underrepre-
sented in weight loss interventions, and with encouragement, may be
more likely to participate and be more successful at weight loss if
referred by their PCP.
In our prior qualitative focus group study among PCPs with patients
in theHopkins POWER trial, several PCPs expressed that their role in the
trial was inﬂuential to patients by providing endorsement and legitima-
cy to the weight loss program (Bennett et al., 2014). Additionally, PCPs
discussed their unusual successwith enrollingmen,which suggests that
menmay bemore receptive to a PCP-endorsedweight loss intervention
and therefore be motivated to lose weight. Although most PCPs agreed
that they wanted to maintain a peripheral role in the weight loss pro-
gram, several expressed concern that their patients did not perceiveTable 2
Adjusted between-group difference in absolute weight loss between referral methods at 6 and
Randomized group Between-group diffe
6 months
Mean (95%CI)
Male Control 0.6 (−2.3, 3.5)
Remote + in-person −1.3 (−4.6, 1.9)
Female Control −0.4 (−1.9, 1.2)
Remote + in-person −0.8 (−2.5, 1.0)
Diabetes Control −0.4 (−3.2, 2.4)
Remote + in-person −1.6 (−5.0, 1.7)
No diabetes Control −0.1 (−1.8, 1.7)
Remote + in-person 0.0 (−1.9, 1.9)
*adjusted for age, race, gender, clinic site.
† p for interaction: 0.81 for gender, 0.93 for diabetes diagnosis.them as taking an active role in the weight loss program and desired
access to timely updates.
Themedical literature supports that PCPs play a key role in the diag-
nosis of obesity and coordination of care for their overweight and obese
patients. Physicians' counseling of weight loss is associated with in-
creased motivation for patients to lose weight and intention to change
lifestyle behaviors (Jay et al., 2010; Huang et al., 2004; Post et al.,
2011). Patients who discuss weight loss with their PCP are more likely
to attempt weight loss (Gudzune et al., 2014; Rose et al., 2013). In our
study, we used PCP referral of patients as a proxy measure of PCP
counseling ofweight loss sincewe believed thatwhen PCPs referred pa-
tients it involved a discussion aboutweight loss andmay have provided
motivation for patients to lose weight.
While our results did not show an association between PCP referral
and weight loss, we know that coordinating care for overweight and
obese patients requires a collaborative effort and partnership among
PCPs, weight loss coaches/interventionists, and patients. PCPs play an
important role in weight loss counseling but less so in leading weight
loss interventions themselves (Wadden et al., 2014). Further research
is needed to examine the right amount of PCP engagement to effectively
leverage their relationships with patients to enhance weight loss24 months, stratiﬁed by gender and diabetes diagnosis.
rence at:
24 months
p-Value Mean (95%CI) p-Value
0.68 −1.6 (−7.5, 4.4) 0.61
0.42 −3.1 (−8.0, 1.7) 0.21
0.67 1.0 (−1.7, 3.8) 0.45
0.40 −1.5 (−3.8, 0.7) 0.18
0.78 −0.0 (−6.1, 6.2) 1.00
0.35 −1.9 (−6.9, 3.0) 0.45
0.94 0.2 (−2.5, 2.9) 0.85
1.00 −1.3 (−3.7, 1.1) 0.28
Table 3
Unadjusted secondary outcomes of patient–PCP relationship quality, and participation
and satisfaction rates.
Outcome PCP
referral
(n = 171)
Non-PCP
referral
(n = 244)
p-Value
Mean % completed coach contacts (SD)a 65.8 (2.6) 65.5 (2.2) 0.93
Mean % completed web logins (SD)a 54.7 (2.7) 56.8 (2.4) 0.57
Mean weighted satisfaction score with
interventiona,b
42.8 (12.3) 44.0 (13.3) 0.48
Mean weighted satisfaction score with PCPa 5.1 (2.5) 4.7 (2.6) 0.31
Mean # reports reviewed with PCP (SD)a 2.3 (1.7) 2.1 (1.6) 0.37
Mean Patient–PCP relationship quality score
(SD)c
29.9 (2.7) 28.7 (4.0) b0.001
a Intervention groups only: n = 114 for PCP recruitment and n = 163 for non-PCP
recruitment.
b Minimum score was 0 with a maximum score of 64 and 72 for remote and in-person
support groups, respectively.
c Minimum summary score was 8 with a maximum score of 32.
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focus on streamlining the referral process using the electronic medical
record and keeping PCPs optimally engaged by developing accessible
and efﬁcient strategies (e.g., web-based reports on weight progress)
to facilitate communication between PCPs, weight loss coaches and
patients (Bennett et al., 2014).
Study limitations and strengths
The major strength of our study is that we evaluated data from a
primary-care based weight loss intervention, which means that PCPs
were actively involved in the trial. Unlike other weight loss trials, the
Hopkins POWER trial was speciﬁcally designed to recruit participants
from primary care practices and to involve PCPs in certain aspects
of the trial, including recruitment, reviewing weight loss reports and
encouraging patient participation.
There are several limitations to our study. First, it is possible we did
not ﬁnd an association between PCP referral and weight loss because
the trial was designed with an active but limited role for the PCP, who
reviewed on average two weight loss reports with their patients during
the 24 month trial (Bennett et al., 2015). Moreover, the trial was not
designed nor powered to study the effect modiﬁcation of gender and
diabetes status onweight loss. Second, we donot knowwhether PCP re-
ferral was a proxy for another measure, such as a chance appointment
with the PCP during recruitment for a condition unrelated to weight,
or an indicator of frequent contacts with the PCP. Because women (vs.
men) and people with type 2 diabetes are more likely to attend doctor
visits, they may have had more opportunity for referrals. Third, the re-
cruitment method may be inaccurate since it was assessed by a single
question on a telephone screening survey. Because primary care prac-
tices sent letters signed by their PCPs to all eligible patients, patients
may have been misclassiﬁed if they reported the letter as PCP referral.
Finally, we had limited information on the quality of the patient–
provider relationship and are unable to assess whether there was a
change in relationship quality from baseline to trial completion because
we only administered the survey at the end.
Conclusions
Our study represents the ﬁrst of its kind to examine the role of PCP
referral of patients into a practice-based weight loss trial. Although we
did not ﬁnd evidence that PCP referral into a weight loss trial was asso-
ciated with increased weight loss or greater participation, the intensity
of PCP involvement in the POWER study was minimal. Future studies
examining primary care-based weight loss programs need to assess
the optimal amount of PCP engagement to augment patient adherence
and weight loss success, without over-burdening the PCP or practice.Conﬂicts of interest
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